More South Korean tech companies started implementing a work-from-home arrangement due to the coronavirus infections increasing to 15,761.
The list includes Kakao Corp., Naver Corp., Nexon Co., SK Telecom Co., and KT Corp.
According to an official of Kakao Corp., the operator of mobile messaging app Kakao Talk, while there has been no confirmed case among its employees, they have been indefinitely allowed to work from home as a precautionary measure.
Kakao Corp. previously implemented a remote working set up from late February and to July 7.
South Korea's top internet portal operator Naver Corp. also began partial work-from-home arrangements starting last week.
Employees only report at the office twice a week and work at home for four days.
Gaming giant Nexon Co. will also allow a partial work-from-home set-up with employees reporting at the office only twice a week.
SK Telecom Co. will be enforcing a remote-work system until Aug. 23, which would be the third time it has employed the policy since February.
Meanwhile, KT Corp. is adopting a partial work-from-home arrangement until Aug. 23.
Both telecom operators have reported infections in their Seoul headquarters.


OpenAI Revenue Rises 18% in Q2 as Losses Widen and Anthropic Surges Ahead
Lockheed Martin Secures $153.5 Million in U.S. Defense Contracts
Schott Pharma Stock Rises as Barclays Upgrades Rating on Growth Outlook
Google to Move All Pixel Production Out of China by 2027
Google to Buy Spirit Airlines Business Data for $10 Million to Train AI
Toyota, Honda Shares Rise on Possible U.S.-Canada Auto Tariff Cut
SK Hynix Shares Surge on Record $28.6 Billion Buyback
Shein Targets $26B-$27B Valuation for Hong Kong IPO
CK Hutchison Seeks $1.5 Billion From Panama Over Canal Ports
Sun Pharma Wins U.S. Appeal in Pfizer Lipitor Antitrust Case
Standard Chartered Expands Hedge Fund Access for Wealth Clients
SEC Sues Former Tricolor Executives Over $1.9 Billion Investor Fraud Scheme
BofA Sees Micron EPS Topping $230 by 2030, Backs Major Stock Upside
AstraZeneca Halts Phase III Volrustomig Lung Cancer Trial After Efficacy Setback
Nordson Stock Rises as Q3 Earnings Beat Estimates, Outlook Raised
Moderna Short Sellers Hit With $4.8 Billion Loss as Stock Soars 



